IL13 polymorphisms were not found to be associated with genetic risk to type I diabetes, RA, systemic sclerosis (SSc), and Sjögren’s syndrome although serum IL-13 levels were mostly elevated [91]. Here, IL13 is linked to systemic sclerosis.